Synergy Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 94   

Articles published

SGYP 6.77 -0.26 (-3.70%)
price chart
Large Inflow of Money Witnessed in Synergy Pharmaceuticals, Inc.
Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) traded with a cut of -0.06 points or -0.85% at $6.97 per share. As per the last available information, the stock aggregated $0.48 million in upticks and $0.31 million in downticks, keeping the net money flow ...
BTIG Research Rating Update on Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP)
BTIG Research initiates coverage on Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) The brokerage firm has issued a Buy rating on the shares.
Stocks to Keep Your Eyes on: Citrix Systems, Inc. (CTXS), Tesoro (TSO ...  Techsonian (press release)
Synergy Pharmaceuticals Inc (SGYP) Drops 5.28% on August 31
Synergy Pharmaceuticals Inc (SGYP) was one of the Russell 2000's biggest losers for Monday August 31 as the stock slid 5.28% to $7.00, a loss of $-0.39 per share.
Why Synergy Pharmaceuticals, Inc. Shares Are Surging Higher
However, before investors get too excited, they should remember that Synergy Pharmaceuticals is a clinical-stage company without any products on the market or revenue. Also, investors need to remember that there's no guarantee that an FDA approval ...
Why This Analyst Sees Synergy Pharma Still Doubling Even After Huge Gains  24/7 Wall St.
Here's Why Synergy Pharmaceuticals Inc Stock Is Trading 50% Up Today  Bidness ETC
Why Chubb Corp (CB), CalAmp Corp. (CAMP) and Synergy Pharmaceuticals Inc (SGYP ...
U.S. markets opened much higher this morning, but then pared some of those gains over the rest of the day. Traders were again focused on the developments between Greece and its creditors.
Synergy Pharma Said to Consider Sale Ahead of Trial Results
(Bloomberg) -- Synergy Pharmaceuticals Inc., a U.S. developer of drugs for gastrointestinal disorders, is talking to advisers about a potential sale of the company, according to people with knowledge of the matter.
Why Synergy Pharmaceuticals, Inc. Is Surging Higher Today.  Motley Fool
Synergy Pharma exploring sale: Bloomberg  Reuters
Company Shares of Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) Rally 5.42%
Shares of Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) appreciated by 5.42% during the past week but lost 18.97% on a 4-week basis.
Synergy Pharmaceuticals Sees Large Drop in Short Interest (SGYP)  Dakota Financial News
Synergy Pharmaceuticals Sees Significant Decline in Short Interest (SGYP)  WKRB News
Biotech Beat: Gilead Sciences, Inc. (GILD), Synergy Pharmaceuticals Inc (SGYP ...
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) is unfortunately continuing down a bearish trend. At this point, it seems as though the bears simply can't let go of earnings.
Does Synergy Pharma's Plecanatide Blow Away The Competition?
Significant data and corporate information has been released by Synergy Pharma (NASDAQ:SGYP) ("the Company") over the past month, and the big question that many people are asking is how SGYP's leading drug, plecanatide, compares to the ...
Large Outflow of Money Witnessed in Synergy Pharmaceuticals, Inc.
Synergy Pharmaceuticals, Inc. (SGYP:NASDAQ) jumped 0.32 points or 3.67% on strong buying and was last priced at $8.91 per share.
Shares of Synergy Pharmaceuticals, Inc. (SGYP:NASDAQ) Sees Large Inflow of ...  Insider Trading Report
Synergy Pharmaceuticals Given "Buy" Rating at Canaccord Genuity (SGYP)  sleekmoney